Smoking cessation lowers risk of AFib
Smoking cessation can significantly reduce a person’s risk of developing atrial fibrillation compared to those who continue smoking. Researchers reported this finding on Sept. 11 in JACC: Clinical… read more.
Smoking cessation can significantly reduce a person’s risk of developing atrial fibrillation compared to those who continue smoking. Researchers reported this finding on Sept. 11 in JACC: Clinical… read more.
Hypertonic saline (HS) nasal drop treatment can reduce by two days the length of the common cold in children, researchers reported on September 6. 2024 at the European… read more.
Using hypertonic saline nasal drops can reduce the length of the common cold in children by two days, according to a study that will be presented at the… read more.
Young people who vape perform worse than non-vapers in tests designed to measure their capacity for exercise, according to a study presented at the European Respiratory Society (ERS)… read more.
According to research presented today at ESC Congress 2024, 1 patients with stable coronary artery disease who quit smoking at any timepoint after their diagnosis reduced their risk… read more.
Even light smoking of just 1-2 cigarettes a day either before or at any time during pregnancy is significantly associated with major health problems in the newborn, finds… read more.
Inhaler misuse leading to inadequate medication delivery impacts a person’s ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper inhaler use is… read more.
Chronic cough is among the most common reasons for seeking medical care, with middle-aged women the group most affected. New studies at Uppsala University also show that this… read more.
AstraZeneca’s Fasenra (benralizumab) has been approved in China by the country’s National Medical Products Association (NMPA) for the maintenance treatment of patients 12 years of age and older… read more.
Data from nearly 6000 smokers with cancer show that it may be easier to predict who will stop smoking than was previously thought. It is often important to… read more.
Pfizer Inc. announced positive top-line safety and immunogenicity results from sub-study B of the ongoing pivotal Phase III clinical trial ( NCT05842967 ) MONeT (RSV I Mmunizati ONStudy… read more.
New use of semaglutide was associated with a lower risk for medical care related to tobacco use disorder (TUD) in smokers with type 2 diabetes compared with 7… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.